A new study presents a chemoresistance test aimed at predicting personalized therapeutic responses in pediatric patients with clivus chordoma. This research could enhance treatment strategies for this rare tumor type.
prediction of personalized therapeutic response in pediatric clivus chordoma chemoresistance test
Original title: “Prediction of personalized therapeutic response in pediatric clivus chordoma: chemoresistance test.”